The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 105.00
Bid: 102.00
Ask: 108.00
Change: 0.00 (0.00%)
Spread: 6.00 (5.882%)
Open: 105.00
High: 105.00
Low: 105.00
Prev. Close: 105.00
IGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

8 Apr 2010 07:00

RNS Number : 8639J
Intercede Group PLC
08 April 2010
 



8 April 2010

Intercede Group plc

("Intercede")

 

Trading Update for the Full Year to 31 March 2010

 

We are pleased to report that Intercede is continuing to experience growth in sales revenues, pre-exceptional operating profit and cash.

 

Revenues for the year ended 31 March 2010 are expected to be approximately 10% ahead of the previous year's reported revenues of £5.7m. This is a strong performance in a difficult economic market. However, with sales slightly below expectations and having maintained our planned investment for the growth of the business, the pre-exceptional operating profit for the year (2009: £1.9m) will be ahead of last year but lower than market expectations.

 

Cash balances at 31 March 2010 total £4.7m which compares to £3.7m at 31 March 2009.

 

As previously announced, the US and UK patent litigations involving ActivIdentity were settled on 23 March 2010. The exceptional charge to the current financial year for all of the legal fees and associated costs relating to this case is expected to be in the region of £1.5m. No further legal costs are expected to arise and, as previously advised, it is not anticipated that the patent license agreement included within the settlement will have a material impact on Intercede's current or future earnings.

 

Intercede Chairman and Chief Executive Richard Parris said:

 

 "I am pleased to report an improved trading performance against a backdrop of the increasing adoption of our technology by national governments, managed service providers and large enterprise customers. Our increasing market penetration has not only provided financial returns in the current period but is also creating annuity revenue streams for the future."

 

Intercede expects to announce its full year results for the year ended 31 March 2010 by mid June 2010.

 

About Intercede

 

Intercede is the producer of the MyID® Identity and Credential Management System (IDCMS). Intercede's MyID is the only IDCMS software product that enables organizations to easily and securely manage the identities of people and their associated identity credentials within a single, integrated, workflow driven platform. This includes enabling and managing: secure registration, biometric capture, application vetting and approval through to smart card personalisation, issuance and management.

 

Intercede's MyID is being used around the world by large corporations, governments and banks to manage millions of identities for employees, citizens and customers. Notable deployments in the US include 10 Federal Agencies, a program with Lockheed Martin and two major US financial institutions. In Europe and the Middle East, Intercede's MyID is being deployed in support of government identity, health and corporate employee ID security projects.

 

For more information visit http://www.intercede.com

 

ENQUIRIES

Intercede Group plc

Richard Parris, Chairman & Chief Executive

Andrew Walker, Finance Director

Tel. +44 (0)1455 558111

FinnCap

Clive Carver- Corporate Finance

Joanna Weaving - Corporate Broking

Tel. +44 (0)20 7600 1658

Pelham Bell Pottinger

Archie Berens / Francesca Tuckett

Tel. +44 (0)20 7337 1509

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSSWEFWFSSELL
Date   Source Headline
25th Sep 20131:00 pmRNSResult of AGM
25th Sep 20137:00 amRNSContract Wins and AGM Statement
9th Sep 20137:00 amRNSDirectors' Holding
29th Jul 20137:00 amRNSContract awards and Trading update
17th Jun 20137:00 amRNSDirector/PDMR Shareholding
4th Jun 20137:00 amRNSFinal Results
25th Apr 20137:00 amRNSContract Win
16th Apr 20137:00 amRNSAppointment of Non-Executive Director
5th Apr 20137:00 amRNSYear end trading update
1st Feb 20137:00 amRNSTrading Update
3rd Dec 20127:00 amRNSHolding(s) in Company
22nd Nov 20127:00 amRNSInterim Results
4th Oct 20127:00 amRNSTrading Update
26th Sep 20124:39 pmRNSResult of AGM
21st Aug 20127:00 amRNSAmendments to LTIP
4th Jul 20123:35 pmRNSDirector/PDMR Shareholding
14th Jun 20122:37 pmRNSIssue of Equity
12th Jun 201210:13 amRNSDirector/PDMR Shareholding and Issue of equity
5th Apr 20127:00 amRNSYear End Trading Update
15th Mar 20121:02 pmRNSIssue of Equity
17th Feb 20127:00 amRNSDirector/PDMR Shareholding
16th Feb 20127:00 amRNSTrading Update
12th Dec 20117:00 amRNSUS Expansion
7th Dec 201112:00 pmRNSSales Alliance
1st Dec 20117:00 amRNSInterim Results
14th Nov 20117:00 amRNSNew Partnership
4th Oct 20117:00 amRNSNew Contract Win
21st Sep 20112:55 pmRNSResult of AGM
21st Sep 20117:00 amRNSAGM Statement and Update
17th Aug 20117:00 amRNSDirector/PDMR Share Option Awards
4th Aug 20113:39 pmRNSDirector/PDMR Shareholding
7th Jun 20117:00 amRNSFinal Results
7th Apr 20117:00 amRNSTrading Update
18th Jan 20119:32 amRNSDirector/PDMR Shareholding
6th Dec 20107:00 amRNSTransaction in Own Shares
30th Nov 201011:02 amRNSAdditional Listing and Director dealing
29th Nov 20107:00 amRNSIntercede Group Interim Results
4th Nov 20107:00 amRNSReduction of Share Capital
7th Oct 20107:54 amRNSPositive Trading Update
30th Sep 20107:00 amRNSNew Contract Win
24th Sep 20102:00 pmRNSResult of AGM
22nd Sep 20107:00 amRNSNew Contract Win
7th Sep 20107:00 amRNSPositive Trading Update
15th Jul 20107:00 amRNSLaunch of latest version of MyID PIV
6th Jul 20103:48 pmRNSChange of name of adviser
10th Jun 20107:00 amRNSFinal Results
8th Apr 20107:00 amRNSTrading Update
25th Mar 201012:30 pmRNSSettlement of Patent Dispute
2nd Mar 20107:00 amRNSDirector/PDMR Shareholding
1st Mar 20102:00 pmRNSMajor Subcontract with Thales

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.